EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality

Frank Lezoualc'h, Lina Badimon iD, Hana Baker, Monique Bernard, Gabor Czibik, Rudolf A de Boer iD, Thomas D'Humières, Micheline Kergoat, Mark Kowala, Jennifer Rieusset, Gemma Vilahur, Maximin Détrait und 2 weitere

Cardiovascular Research · 2023

DOI: 10.1093/cvr/cvac152 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, 2023. Verfasst von Frank Lezoualc'h und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institut des Maladies Métaboliques et Cardiovasculaires, INSERM, Université Paul Sabatier, UMR 1297-I2MC, 1 avenue Jean Poulhès - BP 84225 - 31432 To…. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Diabetes Mellitus, Type 2, Insulin Resistance, Coronary Artery Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 269 Literaturangaben. Gefördert von: Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic cardiomyopathy (CM), occurring in the absence of hypertension, coronary artery disease, and valvular or congenital heart disease, is now recognized as a distinct, multifactorial disease leading to ventricular hypertrophy and abnormal myocardial contractility that correlates with an array of complex molecular and cellular changes. Animal models provide the unique opportunity to investigate mechanistic aspects of diabetic CM, but important caveats exist when extrapolating findings obtained from preclinical models of diabetes to humans. Indeed, animal models do not recapitulate the complexity of environmental factors, most notably the duration of the exposure to insulin resistance that may play a crucial role in the development of diabetic CM. Moreover, most preclinical studies are performed in animals with uncontrolled or poorly controlled diabetes, whereas patients tend to undergo therapeutic intervention. Finally, whilst type 2 diabetes mellitus prevalence trajectory mainly increases at 40- < 75 years (with a currently alarming increase at younger ages, however), it is a legitimate concern how closely rodent models employing young animals recapitulate the disease developing in old people. The aim of this review is to identify the current limitations of rodent models and to discuss how future mechanistic and preclinical studies should integrate key confounding factors to better mimic the diabetic CM phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesDiabetes Mellitus, Type 2Insulin ResistanceCoronary Artery DiseaseAnimalsHumansMyocardium

Stichwörter der Autor:innen

Diabetic cardiomyopathyHeart FailureInsulin resistanceOrgan-to-organ interactionType 2 diabetes mellitus

Autor:innen und Institutionen

  • Institut des Maladies Métaboliques et Cardiovasculaires, INSERM, Université Paul Sabatier, UMR 1297-I2MC, 1 avenue Jean Poulhès - BP 84225 - 31432 Toulouse Cedex 4, France.
  • Cardiovascular Program-ICCC, IR-Hospital de la Santa Creu I Sant Pau, IISantPau, CiberCV, C/ de Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain.
  • Diabetes and Complications Research, Lilly Research Laboratories, Eli Lilly and Company, 307 E Merrill St, Indianapolis, IN 46225, USA.
  • Aix-Marseille University, CNRS, CRMBM, Faculté de Médecine, 27 Bd Jean Moulin, 13385 Marseille, France.
  • Department of Physiology, INSERM U955, Université Paris Est Créteil (UPEC), AP-HP, Henri Mondor Hospital, FHU SENEC, Faculté de Santé de Créteil, 8 rue du Général Sarrail, 94010 Créteil cedex, France.
  • Department of Cardiology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands.

ORCID-Profile: Lina Badimon, Rudolf A de Boer, Chris Watson, Geneviève A Derumeaux

Förderung

  • Innovative Medicines Initiative

Zitieren

APA

Lezoualc'h, F., Badimon, L., Baker, H., Bernard, M., Czibik, G., de Boer, R. A., D'Humières, T., Kergoat, M., Kowala, M., Rieusset, J., Vilahur, G., Détrait, M., Watson, C., & Derumeaux, G. A. (2023). Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality. Cardiovascular Research. https://doi.org/10.1093/cvr/cvac152

Vancouver

Lezoualc'h F, Badimon L, Baker H, Bernard M, Czibik G, de Boer RA, et al. Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality. Cardiovascular Research. 2023. doi:10.1093/cvr/cvac152

BibTeX
@article{Lezoualch2023,
  author = {Lezoualc'h, Frank and Badimon, Lina and Baker, Hana and Bernard, Monique and Czibik, Gabor and de Boer, Rudolf A and D'Humières, Thomas and Kergoat, Micheline and Kowala, Mark and Rieusset, Jennifer and Vilahur, Gemma and Détrait, Maximin and Watson, Chris and Derumeaux, Geneviève A},
  title = {Diabetic cardiomyopathy: the need for adjusting experimental models to meet clinical reality},
  journal = {Cardiovascular Research},
  year = {2023},
  doi = {10.1093/cvr/cvac152}
}
Kostenlos starten →